Drugs average development costs

Total drug development costs are huge. It has been estimated recendy that development costs are about US 350 million per drug and annual average sales are US 265 million.Currently, development costs are increasing by between 8% and 11% per annum, and soon average development costs may reach US 500 million for each major product. The... 

The patent system is an essential foundation of the biotechnology industry Through patent protection, those spending extraordinary amounts of money on research and development are able to recoup costs and earn appropriate returns for shareholders by benefiting from limited periods of exclusivity over their discoveries. The importance of this protection becomes obvious as one considers that the average research and development costs for a single new drug has traditionally been estimated at 500 million (Robbins-Roth,... 

States now takes twelve to fifteen years and costs the manufacturer on average more than 800 million, by far the highest price tag in the world. Profits only sometimes offset these costs, and a Duke University study reveals a sobering corollary—fewer than three out of every ten drug products generate revenues that cover their development costs.8... 

Before biotechnology had been intensively introduced to industrial research, developing costs of each drug had cost companies on average US 880 million and had taken 15 years from start to market authorization. About 75% of these costs were spent on failures. Using genomic technologies, there is a realistic chance of... 

The process of drug discovery and development today is vastly more complex and expensive than a century ago. The Tufts Center for the Study of Dmg Development estimated in 2001 that the average approval cost per new prescription drug is 802 million which was based on information m 10 companies included were expenses of project failures and the impact that long development times have on investment costs (4). The development process. 

---